X
XTL Biopharmaceuticals Ltd. (XTLB)
NCM – Real vaqt narxi. Valyuta: USD
2.69
+0.04 (1.51%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
2.83
+0.14 (5.20%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.69
+0.04 (1.51%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
2.83
+0.14 (5.20%)
Bozordan keyin: Aug 12, 2026, 4:10 PM EDT
XTL Biopharmaceuticals Ltd. biotexnologiya kompaniyasi Isroilda autoimmün kasalliklarni davolash uchun farmatsevtik dorilarni sotib olish va ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy dori nomzodi hCDR1 bo'lib, u tizimli qizil yug'on va Shogren sindromini davolash uchun II-faza tayyor aktividir. Kompaniya turli ko'rsatkichlar uchun hCDR1ni tadqiq qilish, ishlab chiqish va tijoratlashtirish bo'yicha Yeda Research and Development Company Limited bilan litsenzion kelishuvga ega. Kompaniya ilgari Xenograft Technologies Ltd. nomi bilan tanilgan va 1995 yil iyul oyida XTL Biopharmaceuticals Ltd. deb nomini o'zgartirgan. XTL Biopharmaceuticals Ltd. 1993 yilda tashkil etilgan va shtab-kvartirasi Isroilning Herzliya shahrida joylashgan.
There is no data to display
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-05 | 6-K | ea0300815-6k_xtlbiophar.htm |
| 2026-07-21 | 6-K | ea0298779-6k_xtlbio.htm |
| 2026-06-30 | 20-F | ea0296095-20f_xtlbio.htm |
| 2026-06-29 | 6-K | ea0296376-6k_xtlbio.htm |
| 2026-06-23 | 6-K | ea0295469-6k_xtlbio.htm |
| 2026-05-22 | 6-K | ea0291904-6k_xtlbio.htm |
| 2026-05-15 | 6-K | ea0291180-6k_xtlbio.htm |
| 2026-05-07 | 6-K | ea0289561-6k_xtlbio.htm |
| 2026-04-29 | 6-K | ea0288126-6k_xtlbio.htm |
| 2026-03-10 | 6-K | ea0280782-6k_xtlbio.htm |